(NASDAQ: CGC) Canopy Growth's forecast annual revenue growth rate of 0.22% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Canopy Growth's revenue in 2024 is $246,670,895.On average, 4 Wall Street analysts forecast CGC's revenue for 2025 to be $20,672,536,929, with the lowest CGC revenue forecast at $20,173,684,472, and the highest CGC revenue forecast at $21,238,814,192.
In 2026, CGC is forecast to generate $22,575,009,860 in revenue, with the lowest revenue forecast at $21,919,440,284 and the highest revenue forecast at $23,230,579,436.